| Bioactivity | TLC388 is a novel camptothecin analog with limited antitumor activity in metastatic NEC[1]. |
| CAS | 1432468-79-5 |
| Formula | C39H30N8O15 |
| Molar Mass | 850.70 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ming-Huang Chen, et al. An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas. Oncologist. 2020 May;25(5):e782-e788. |